Home » News » OnenessPoint Company » Synthetic Biology Automated Strain Transformation Platform of OnenessPoint Lands in Nanjing Pharmaceutical Valley

Synthetic Biology Automated Strain Transformation Platform of OnenessPoint Lands in Nanjing Pharmaceutical Valley

Views: 0     Author: Site Editor     Publish Time: 2022-06-10      Origin: Site

On May 6th, the landing ceremony of "Synthetic Biology Automated Strain Transformation Platform" was held in Jiangbei New District Biomedical Valley. This project is a milestone in the development of high-throughput strains, especially in the development of synthetic strains of terpenoids and fatty acid derivatives, and the development of strains based on non-model organisms.


OnenessPoint is a synthetic biology high-tech enterprise in a rapid development period. With the goal of developing and producing sustainable bio-based products, relying on its own R&D intelligent platform and high-efficiency strain R&D platform, providing full-chain solutions in various fields, empowering the bottom upgrade of industrial raw materials.



Based on the company's technology accumulation in synthetic biology component library, strain library, enzyme engineering technology, gene editing technology, metabolic network design technology, high-throughput strain construction and screening technology, and with the relevant resources from the cooperative laboratories of Beijing University of Chemical Technology and Institute of Microbiology of Chinese Academy of Sciences, OnenessPoint's "automated strain transformation platform" can realize the development, iterative optimization, small trial and pilot test of various new production strains quickly and efficiently.


If you have any questions, please contact us via email or telephone and we will get back to you as soon as possible.

Products

Quick Links

Contact Us

Copyright© 2022 OnenessPoint. | Sitemap